Small caps round-up: Transense, Eckoh, Maxima and Eden

Sensors specialist Transense Technologies has announced that its trading division, IntelliSAW, has entered into a strategic distribution agreement with Simpro Engineering, which provides power protection and control systems technology to the electric power industry. As part of this agreement Simpro will provide distribution for IntelliSAW's innovative wireless/passive electrical switchgear temperature monitoring system in the Malaysian market. Simpro will also work closely with IntelliSAW in developing other Southeast Asian markets.

Speech recognition specialist Eckoh has signed a new contract worth a minimum of £1.1m per annum with a global financial services company to provide a dedicated VoiceXML telephony platform for handling their customer self-service enquiries from across the globe. The company also unveiled its full year results, which saw it deliver a turnover of £10.4m (2011: £6.7m), pre-tax profit of £1.3m (2011: loss £0.6m) and earnings before interest, tax, depreciation and amortisation of £2.1m (2011: £1.2m). Cash levels remained stable at £5.37m.

Maxima Holdings, an information technology business systems and managed services company, has secured two key networking and security solution contracts totalling £1.75m. The first of these includes a contract with a leading UK telecommunications company to deliver a major security solution valued at £1.0m and the second is with a major UK government executive agency to provide a major networking project valued at £750k. "These recent contract successes clearly demonstrate that our turnaround strategy is on track," the firm commented.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Eden Research said on Tuesday that it is "disappointing" to see that its share price has fallen since joining AIM, but was keen to emphasise that it will be "maximising the value of its IP [intellectual property] through the development of existing and new commercial opportunities". The company's European review process will be completed within the next 12 months, which the firm believes will inherently increase the value of the IP it has. In addition, next year the company expects to see the first product registrations coming through in the agrochemical sector, as well as sales of products which incorporate Eden's technologies in the animal health and biocide markets where the regulatory requirements are much simpler than in the agrochemicals sector.

NR